You are subscribed to the Dermatology Times eNews.
eNewsletter Subscribe
Print/Digital Edition Subscribe
April 13, 2015
Web Version | Digital Edition | Share with a colleague
Like Tweet
THIS MONTH IN SKIN CANCER
Clues about genetic alterations that underlie their disease. » Factors
Powerful predictors of metastatic risk. » Study results
Study finds benefits in selected head-and-neck squamous-cell carcinoma cases.» Benefits of erlotinib.
RECOMMENDED ARTICLES:
GEP test for melanoma proves accurate in validation study
Immunotherapy promising for advanced melanoma
Melanoma cells die when denied access to glutamine
New GEP test predicts metastatic risk
New Job Opportunities
AZ - Arizona Skin & Laser
CA - Integrated Dermatology
CA - UC Irvine Health Dept Of Dermatology
CA - MedDerm Associates
CO - Integrated Dermatology
CT - Integrated Dermatology
District of Columbia-Integrated Dermatology
FL - Integrated Dermatology
FL - Palm Beach Dermatology
HI - Sleep Center Hawaii
IL - Integrated Dermatology
MI - Fivenson Dermatology PLLC
National - Leavitt Management Group
National - Integrated Dermatology
NC - Integrated Dermatology
NM - Integrated Dermatology
NY - Company Confidential
NY - Juva Skin & Laser Center
OK - Tulsa Cancer Institute
OR - Cynthia Dreyer, MD
TX - The University of Texas Health Science Center at San Antonio School of Medicine/Dermatology
UT - Integrated Dermatology
WI - Gundersen Lutheran Health System
Editorial Questions? Contact the Editorial Team. Click Here. Sales, Reprints, Classified questions? Contact the Sales Team. Click Here.